Skip to main content
. 2021 Apr 27;11(2):e20. doi: 10.5415/apallergy.2021.11.e20

Table 1. Baseline demographics and characteristics of patients (n = 214).

Characteristic Value
Age at time of desensitization (yr) 59.3 ± 12.4
≥50 years old 167 (78.0)
Body mass index* (kg/m2) 26.5 ± 4.8
18.5–22.9 37 (17.3)
23.0–27.4 90 (42.1)
≥27.5 76 (35.5)
Male sex 150 (70.1)
Race
Chinese 153 (71.5)
Malay 28 (13.1)
Indian 22 (10.3)
Others 11 (5.1)
Smoking status
Never 139 (65.0)
Current 42 (19.6)
Ex 33 (15.4)
Comorbidities
Diabetes mellitus 68 (31.8)
Musculoskeletal and bone conditions 36 (16.8)
Chronic kidney disease 29 (13.6)
Atopic disease 25 (11.7)
Others 67 (31.3)
Regular medications used
Beta-blocker 108 (50.5)
ACE-inhibitor 41 (19.2)
Antihistamine 7 (3.3)
Immunosuppressant 6 (2.8)
Leukotriene receptor antagonist 2 (0.9)

Values are presented as mean ± standard deviation or number (%).

*One patient did not have documented height and weight; body mass index classification (Asians): normal, 18.0–22.9 kg/m2; overweight, 23.0–27.4 kg/m2; obese, ≥27.5 kg/m2. Includes Eurasian, Sikh, Filipino, Burmese and Bangladeshi. Includes asthma and allergic rhinitis.